Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Patients Who May Benefit Most Tirzepatide may be appropriate for patients who: Struggle to lose weight despite consistent effort Have prediabetes or Type 2 diabetes Experience PCOS-related weight gain Have elevated fasting insulin levels Carry excess abdominal or visceral fat Have a family history of diabetes Who May Not Be a Candidate Tirzepatide may not be appropriate for patients with: A history of medullary thyroid cancer Certain endocrine disorders Pregnancy or breastfeeding Severe gastrointestinal intolerance without supervision All eligibility decisions at Geneva are physician evaluated
Levocarnitine [inn] 84
The recommended areas are the abdomen (at least two inches away from the belly button), the front of the thigh, or the back of the upper arm
Week 1-2: Isometric contractions only
